{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:57:11Z","timestamp":1776301031394,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1053\/bega.1999.0064","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"133-145","source":"Crossref","is-referenced-by-count":10,"title":["Consequences of Helicobacter pylori cure in ulcer patients"],"prefix":"10.1053","volume":"14","author":[{"given":"Joachim","family":"Labenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.1999.0064_RF1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042737-199901000-00003","article-title":"Helicobacter pylori 1988\u20131998","volume":"11","author":"McColl","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0064_RF2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection","volume":"93","author":"Howden","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","volume":"41","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000007522","article-title":"Treatment of peptic ulcer","volume":"59","author":"Tytgat","year":"1998","journal-title":"Digestion"},{"key":"10.1053\/bega.1999.0064_RF5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2036.1997.80252000.x","article-title":"One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcer","volume":"11","author":"Labenz","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/gut.34.9.1167","article-title":"Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized and controlled study","volume":"34","author":"Labenz","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(94)91460-5","article-title":"Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial","volume":"343","author":"Hosking","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0064_RF8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","article-title":"Antibacterial treatment of gastric ulcers associated with Helicobacter pylori","volume":"332","author":"Sung","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0064_RF9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0016-5085(99)70119-8","article-title":"The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies","volume":"116","author":"Lind","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH-1 study","volume":"1","author":"Lind","year":"1996","journal-title":"Helicobacter"},{"key":"10.1053\/bega.1999.0064_RF11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.41.1.43","article-title":"Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study","volume":"41","author":"Lam","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2008-1042964","article-title":"Healing of peptic ulcer by eradicating Helicobacter pylori: is one week's treatment adequate?","volume":"121","author":"Labenz","year":"1996","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1053\/bega.1999.0064_RF13","first-page":"A93","article-title":"Antimicrobials accelerate healing of duodenal ulcer (DU) when given with proton pump inhibitors (PPI) or H2-receptor antagonists (H2RA): a meta-analysis","volume":"41","author":"Huang","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2036.1996.40182000.x","article-title":"Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease","volume":"10","author":"Penston","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1572-0241.1998.00333.x","article-title":"The impact of Helicobacter pylori eradication on peptic ulcer healing","volume":"93","author":"Treiber","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-flammatory drugs: HELP NSAIDs study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0064_RF17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.44.4.468","article-title":"Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole","volume":"44","author":"Gillen","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","article-title":"Helicobacter pylori augments the pH increasing effect of omeprazole in patients with duodenal ulcer","volume":"110","author":"Labenz","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.37.6.743","article-title":"Effect of curing Helicobacter pylori on intragastric pH during treatment with omeprazole","volume":"37","author":"Verd\u00fa","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF20","first-page":"387","article-title":"Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era","volume":"92","author":"Neil","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/gast.1996.v110.pm8613015","article-title":"Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review","volume":"110","author":"Hopkins","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF22","first-page":"204","article-title":"What do we really know about Helicobacter pylori in gastric ulcer disease?","volume":"29","author":"Labenz","year":"1997","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1365-2036.1998.00351.x","article-title":"Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence","volume":"12","author":"Neil","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/gast.1997.v113.pm9322501","article-title":"Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study","volume":"113","author":"van der Hulst","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(94)91111-8","article-title":"Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow-up","volume":"343","author":"Forbes","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0064_RF26","first-page":"1785","article-title":"Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure ofHelicobacter pylori infection","volume":"89","author":"Labenz","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF27","first-page":"1221","article-title":"Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens","volume":"90","author":"Xia","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/00365529850172485","article-title":"Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it","volume":"33","author":"Gisbert","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1023\/A:1018827322470","article-title":"Recurrence of Helicobacter pylori infection after successful eradication. Nature and possible causes","volume":"42","author":"Xia","year":"1997","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0064_RF30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0016-5085(98)70475-5","article-title":"A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China)","volume":"114","author":"Mitchell","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/514023","article-title":"Helicobacter pylori reinfection is virtually absent after successful eradication","volume":"176","author":"van der Hulst","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/bega.1999.0064_RF32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005176-199811000-00009","article-title":"Helicobacter pylori reinfection rates in children after eradication therapy","volume":"27","author":"Kato","year":"1998","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1053\/bega.1999.0064_RF33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2007-1005416","article-title":"Ulcers and gastritis","volume":"28","author":"Tytgat","year":"1996","journal-title":"Endoscopy"},{"key":"10.1053\/bega.1999.0064_RF34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/gut.36.6.831","article-title":"Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses","volume":"36","author":"Sch\u00fctze","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/gut.37.1.30","article-title":"Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting","volume":"37","author":"Xia","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF36","first-page":"28","article-title":"Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study","volume":"30","author":"Manes","year":"1998","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF37","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/j.1572-0241.1998.00711.x","article-title":"Epidemiology of peptic ulcer disease in cirrhotic patients: role of Helicobacter pylori infection","volume":"93","author":"Calvet","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2036.1997.146322000.x","article-title":"Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output","volume":"11","author":"Harris","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/gut.34.6.762","article-title":"A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration","volume":"34","author":"McColl","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(95)90374-7","article-title":"Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease","volume":"109","author":"El-Omar","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF41","first-page":"1409","article-title":"Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials","volume":"93","author":"Laine","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1572-0241.1998.167_b.x","article-title":"Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?","volume":"93","author":"Jyotheeswaran","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0016-5085(95)90570-7","article-title":"Risk factors associated with refractory peptic ulcer","volume":"109","author":"Lanas","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.35.1.19","article-title":"Evidence for the essential role of Helicobacter pylori in gastric ulcer disease","volume":"35","author":"Labenz","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF45","series-title":"Ulkusalmanach 1 + 2","first-page":"11","article-title":"Epidemiologie, nat\u00fcrlicher Verlauf und Risikofaktoren der Ulkuskrankheit","author":"Blum","year":"1990"},{"key":"10.1053\/bega.1999.0064_RF46","first-page":"283","article-title":"Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications","volume":"87","author":"Powell","year":"1994","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/bega.1999.0064_RF47","first-page":"199","article-title":"One-year follow-up of duodenal ulcers after one-week triple therapy for Helicobacter pylori","volume":"89","author":"Sung","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199402103300602","article-title":"A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer","volume":"320","author":"Jensen","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0064_RF49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0016-5107(97)70114-7","article-title":"Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori -associated peptic ulcer bleeding","volume":"46","author":"Riemann","year":"1997","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1053\/bega.1999.0064_RF50","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/S0016-5085(98)80353-3","article-title":"Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomized study","volume":"114","author":"Chan","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF51","first-page":"323","article-title":"Symptom relief and the placebo effect in the trial of an anti-peptic drug","volume":"21","author":"McDonald","year":"1980","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF52","first-page":"1539","article-title":"The prevalence of esophagitis in patients with duodenal ulcer","volume":"91","author":"Boyd","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2036.1995.tb00410.x","article-title":"Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer","volume":"9","author":"Reilly","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2036.1996.36178000.x","article-title":"Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole","volume":"10","author":"Bell","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF55","doi-asserted-by":"crossref","first-page":"A212","DOI":"10.1016\/S0016-5085(98)80862-7","article-title":"Does cure of Helicobacter pylori infection induce heartburn?","volume":"114","author":"Malfertheiner","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/gut.42.5.618","article-title":"Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer","volume":"42","author":"McColl","year":"1998","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bmj.312.7027.349","article-title":"Absence of dyspeptic symptoms as a test for Helicobacter pylori eradication","volume":"312","author":"Phull","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0064_RF58","first-page":"614","article-title":"Health impact of peptic ulcer in the United States","volume":"92","author":"Sonnenberg","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00365529609095546","article-title":"Quality of life and Helicobacter pylori eradication","volume":"31","author":"Wilhelmsen","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/00365529409094873","article-title":"On the natural history of peptic ulcer","volume":"29","author":"Lindell","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF61","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1572-0241.1998.00410.x","article-title":"The impact of peptic ulcer disease and infection with Helicobacter pylori on life expectancy","volume":"93","author":"Inadomi","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.40.2.247","article-title":"Relation between gastric cancer and previous peptic ulcer disease","volume":"40","author":"Molloy","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1026677728175","article-title":"Extradigestive manifestations of Helicobacter pylori infection","volume":"44","author":"Realdi","year":"1999","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.1999.0064_RF64","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0016-5085(97)80010-8","article-title":"How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology","volume":"113","author":"Calam","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00042737-199804000-00002","article-title":"Gastrin and colorectal cancer: where now?","volume":"10","author":"Penman","year":"1998","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0064_RF66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0016-5085(98)70193-3","article-title":"Gastrin and colorectal cancer: a prospective study","volume":"115","author":"Thorburn","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2036.1997.145321000.x","article-title":"Clinical economics review: Helicobacter pylori -associated peptic ulcer disease","volume":"11","author":"Bodger","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.1999.0064_RF68","first-page":"A43","article-title":"Comparative cost-effectiveness of three ulcer therapies","volume":"112","author":"Sonnenberg","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF69","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/bmj.316.7143.1507","article-title":"Helicobacter pylori and gastric diseases","volume":"316","author":"Blaser","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0064_RF70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.43.3.327","article-title":"Opposing time trends of peptic ulcer and reflux disease","volume":"43","author":"El-Serag","year":"1998","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/gut.41.3.277","article-title":"Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?","volume":"41","author":"Labenz","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF72","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0016-5085(98)70364-6","article-title":"The seroprevalence of cagA -positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease","volume":"115","author":"Vicari","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF73","first-page":"588","article-title":"An inverse relationship between cagA+strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinomas","volume":"58","author":"Chow","year":"1998","journal-title":"Cancer Research"},{"key":"10.1053\/bega.1999.0064_RF74","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1572-0241.1999.982_e.x","article-title":"Helicobacter pylori and the efficacy of omeprazole for gastro-esophageal reflux disease","volume":"94","author":"Schenk","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF75","doi-asserted-by":"crossref","first-page":"A105","DOI":"10.1016\/S0016-5085(98)80426-5","article-title":"The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori(Hp) infection: a 4 year prospective study","volume":"114","author":"Di Mario","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF76","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0016-5085(97)70024-6","article-title":"Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis","volume":"112","author":"Labenz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF77","doi-asserted-by":"crossref","first-page":"A113","DOI":"10.1016\/S0016-5085(98)80462-9","article-title":"Chronic corpus gastritis is protective against erosive esophagitis","volume":"114","author":"El-Serag","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF78","doi-asserted-by":"crossref","first-page":"A124","DOI":"10.1016\/S0016-5085(98)80506-4","article-title":"Is Helicobacter pylori eradication associated with the endoscopic development of esophagitis?","volume":"114","author":"Friedman","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF79","series-title":"Gastroenterology and Hepatology. The Next Millenium","first-page":"77","article-title":"The role of Helicobacter pylori in gastroesophageal reflux disease","author":"Malfertheiner","year":"1998"},{"key":"10.1053\/bega.1999.0064_RF80","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1572-0241.1998.00523.x","article-title":"Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad","volume":"93","author":"Richter","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF81","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042737-199902000-00002","article-title":"Diseases and problems secondary to massive obesity","volume":"11","author":"Herrara","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0064_RF82","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/bmj.316.7138.1130","article-title":"Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies","volume":"316","author":"Danesh","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.1999.0064_RF83","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/00365529709002994","article-title":"Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases","volume":"32","author":"Parente","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF84","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/gut.44.4.448","article-title":"Omeprazole: Helicobacter pylori makes thee greater yet","volume":"44","author":"Pantoflickowa","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.41.1.33","article-title":"Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer","volume":"41","author":"Labenz","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0064_RF86","first-page":"A151","article-title":"The impact of H. pylori on healing of reflux esophagitis during treatment with pantoprazole","volume":"114","author":"Holtmann","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF87","first-page":"56","article-title":"Does H. pylori infection influence the response to treatment with acid inhibition in patients with gastroesophageal reflux disease (GERD)?","volume":"32","author":"Carlsson","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0064_RF88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0064_RF89","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"New England Journal of Medicine"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T22:54:29Z","timestamp":1555023269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691899900641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S1521691899900641"],"URL":"https:\/\/doi.org\/10.1053\/bega.1999.0064","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}